Home » Topics » BioWorld Science

BioWorld Science
RSS

Second-generation antisense antitumor compound from Hybridon enters clinic

Dec. 16, 1997

Selective COX-2 inhibitors under development at Merck Frosst

Dec. 16, 1997

ViroPharma develops agents for HCV infection

Dec. 16, 1997

5-HT receptor (ant)agonists from Pfizer

Dec. 16, 1997

Natural anti-HIV agent disclosed by Hoechst

Dec. 16, 1997

Searle describes selective alphav/beta3 integrin antagonists

Dec. 16, 1997

Faropenem data presented at Japanese congress

Dec. 16, 1997

SmithKline Beecham licenses rotavirus vaccine

Dec. 16, 1997

New AmBisome data reported

Dec. 16, 1997

87 development projects under way at Zeneca

Dec. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...